CCL2 and Stroke: A meta-analysis of six population-based cohort studies, which included 17,000 individuals without a history of stroke and followed them over 16 years, revealed that higher baseline levels of MCP-1 were linked to an increased risk of stroke, even after adjustment for traditional vascular risk factors.